Investigators

Study information

• Research Area: HIV
• Research type: Prospective longitudinal study
• Start date: Jan 01, 2021
• End date: Dec 31, 2022

Study aim of the objectives

Aim 1. Establish a cohort of individuals who have received PrEP in CA-IeDEA-affiliated health centers in Rwanda and DRC, and identify patterns of PrEP use, adherence and persistence. We will develop a cohort of all individuals who have received at least 1 PrEP prescription since January 1, 2019 and extract routine data from existing clinical registers.

Aim 2. Identify multi-level determinants of PrEP use, adherence, and persistence among individuals in
this cohort. We will collect supplemental quantitative survey and qualitative interview data from a subset of
participants identified in Aim 1 to identify and contextualize multi-level factors associated with PrEP outcomes.

Study setting/Area (Location)

The study will be carried out in 10 health centers in Kigali, Rwanda and DRC

Implementing institution

RMH

Department/Division

Einstein-Rwanda Research & Capacity Building Program/Research for Development (RD Rwanda) & RMH

Impact on Policy

The study findings will inform ongoing prevention efforts, ensure equitable access to novel HIV prevention tools, and help guide policy decisions to address the HIV pandemic.